Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -4.42% is 92% above its 5-year average of -55.08%, near the high end of its 5-year range (-187.58%–21.37%).
13.96% below its 12-month average of -3.88%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3.12%.
NET PROFIT MARGIN
-4.42%
NET PROFIT MARGIN AVG TTM
-3.88%
NET PROFIT MARGIN AVG 3Y
-17.64%
NET PROFIT MARGIN AVG 5Y
-55.08%
NET PROFIT MARGIN AVG 10Y
-167.24%
NET PROFIT MARGIN AVG 15Y
-97.59%
NET PROFIT MARGIN AVG 20Y
-69.44%
CURRENT VS TTM AVG
-13.96%
CURRENT VS 3Y AVG
+74.95%
CURRENT VS 5Y AVG
+91.97%
CURRENT VS 10Y AVG
+97.36%
CURRENT VS 15Y AVG
+95.47%
CURRENT VS 20Y AVG
+93.63%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-1600.00%
vs the sector median at left
Precipio, Inc.
Market Cap
$41.83M
Net Profit Margin
-4.42%
TTM Avg
-3.88%
3Y Avg
-17.64%
5Y Avg
-55.08%
Market Cap
$41.95M
Net Profit Margin
-13.86%
TTM Avg
-1.65%
3Y Avg
-39.69%
5Y Avg
-47.80%
Market Cap
$42.26M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$42.72M
Net Profit Margin
-145.56%
TTM Avg
-153.73%
3Y Avg
-223.84%
5Y Avg
-240.41%
Market Cap
$42.83M
Net Profit Margin
-747.20%
TTM Avg
-525.22%
3Y Avg
-722.73%
5Y Avg
-1271.67%
Market Cap
$42.99M
Net Profit Margin
-84.93%
TTM Avg
-105.50%
3Y Avg
-125.06%
5Y Avg
-177.30%
Market Cap
$39.64M
Net Profit Margin
0.00%
TTM Avg
-111.93%
3Y Avg
-252.09%
5Y Avg
-173.47%
Market Cap
$44.02M
Net Profit Margin
322.77%
TTM Avg
-172.32%
3Y Avg
-215.38%
5Y Avg
-270.73%
Market Cap
$44.71M
Net Profit Margin
32.60%
TTM Avg
-34.66%
3Y Avg
-64.33%
5Y Avg
-204.90%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precipio, Inc. (PRPO) | $41.83M | -4.42% | -3.88% | -17.64% | -55.08% |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | -13.86% | -1.65% | -39.69% | -47.80% |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | -145.56% | -153.73% | -223.84% | -240.41% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -747.20% | -525.22% | -722.73% | -1271.67% |
| CVRx, Inc. (CVRX)vs › | $42.99M | -84.93% | -105.50% | -125.06% | -177.30% |
| Veru Inc. (VERU)vs › | $39.64M | 0.00% | -111.93% | -252.09% | -173.47% |
| DarioHealth Corp. (DRIO)vs › | $44.02M | 322.77% | -172.32% | -215.38% | -270.73% |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 32.60% | -34.66% | -64.33% | -204.90% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | -164.82% | -1870.42% | -1064.08% | -709.38% |
Operating Margin
-5.6%
Net Profit Margin
-4.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -3.12% |
| 2026-03-31 | -22.90% |
| 2025-12-31 | 6.60% |
| 2025-09-30 | -1.28% |
| 2025-06-30 | 1.31% |
| 2025-03-31 | -20.77% |
| 2024-12-31 | -6.70% |
| 2024-09-30 | -12.02% |
| 2024-06-30 | -27.47% |
| 2024-03-31 | -60.58% |
| 2023-12-31 | 21.37% |
| 2023-09-30 | -38.92% |
| 2023-06-30 | -64.90% |
| 2023-03-31 | -107.56% |
| 2022-12-31 | -95.78% |
| 2022-09-30 | -143.52% |
| 2022-06-30 | -90.89% |
| 2022-03-31 | -187.58% |
| 2021-12-31 | -90.55% |
| 2021-09-30 | -82.81% |
| 2021-06-30 | -128.54% |
| 2021-03-31 | -79.61% |
| 2020-12-31 | -96.29% |
| 2020-09-30 | -202.95% |
| 2020-06-30 | -171.94% |
| 2020-03-31 | -263.57% |
| 2019-12-31 | -549.56% |
| 2019-09-30 | -241.96% |
| 2019-06-30 | -627.71% |
| 2019-03-31 | -231.70% |
| 2018-12-31 | -959.85% |
| 2018-09-30 | -592.15% |
| 2018-06-30 | -346.51% |
| 2018-03-31 | -342.56% |
| 2017-12-31 | -1055.56% |
| 2017-09-30 | -2325.93% |
| 2017-06-30 | -1415.38% |
| 2017-03-31 | -267.78% |
| 2016-12-31 | -398.05% |
| 2016-09-30 | -421.44% |
| 2016-06-30 | -197.43% |
| 2016-03-31 | -1383.05% |
| 2015-12-31 | 160.93% |
| 2015-09-30 | -184.32% |
| 2015-06-30 | -46.52% |
| 2015-03-31 | -46.69% |
| 2014-12-31 | -75.27% |
| 2014-09-30 | -1.26% |
| 2014-06-30 | -57.55% |
| 2014-03-31 | -66.81% |
| 2013-12-31 | -64.04% |
| 2013-09-30 | -83.54% |
| 2013-06-30 | -39.24% |
| 2013-03-31 | -48.63% |
| 2012-12-31 | -31.72% |
| 2012-09-30 | -34.91% |
| 2012-06-30 | -6.19% |
| 2012-03-31 | -37.41% |
| 2011-12-31 | 3.07% |
| 2011-09-30 | -15.39% |
| 2011-06-30 | -78.23% |
| 2011-03-31 | -37.14% |
| 2010-12-31 | -15.06% |
| 2010-09-30 | -20.32% |
| 2010-06-30 | -22.49% |
| 2010-03-31 | -5.95% |
| 2009-12-31 | 1.98% |
| 2009-09-30 | -7.25% |
| 2009-06-30 | -13.34% |
| 2009-03-31 | -19.10% |
| 2008-12-31 | -3.58% |
| 2008-09-30 | -9.30% |
| 2008-06-30 | 1.62% |
| 2008-03-31 | 1.95% |
| 2007-12-31 | 3.25% |
| 2007-09-30 | -26.19% |
| 2007-06-30 | 3.60% |
| 2007-03-31 | -22.90% |
| 2006-12-31 | -17.92% |
| 2006-09-30 | -34.34% |
| 2006-06-30 | -6.19% |
| 2006-03-31 | -4.89% |
| 2005-12-31 | -529.71% |
| 2005-09-30 | 1.27% |
| 2005-06-30 | -13.07% |
| 2005-03-31 | -39.22% |
| 2004-12-31 | -87.22% |
| 2004-09-30 | -103.03% |
| 2004-06-30 | -167.93% |
| 2004-03-31 | -44.72% |
| 2003-12-31 | -102.98% |
| 2003-09-30 | -80.89% |
| 2003-06-30 | -55.06% |
| 2003-03-31 | -37.83% |
| 2002-12-31 | -101.13% |
| 2002-09-30 | -52.02% |
